Evidence map›Paper›PMID 33670432›Full record

ArticleDiagnostics (Basel, Switzerland)2021

Primary Ciliary Dyskinesia Diagnostic Challenges: Understanding the Clinical Phenotype of the Puerto Rican

Wilfredo De Jesús-Rojas, Dalilah Reyes-De Jesús, Ricardo A Mosquera

Open access · goldAbstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. TheInternational journal of molecular sciences · 2023
    Review
  10. Article
  11. The Genetics of Primary Ciliary Dyskinesia in Puerto Rico.Diagnostics (Basel, Switzerland) · 2022
    Article
  12. NovelFrontiers in genetics · 2022
    Article
  13. Article
  14. Emerging Genotype-Phenotype Relationships in Primary Ciliary Dyskinesia.International journal of molecular sciences · 2021
    Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Wilfredo De Jesús-RojasDepartment of Pediatrics, Medical Sciences Campus, School of Medicine, University of Puerto Rico, San Juan 00921, Puerto Rico.ORCID 0000-0002-6133-3517
Dalilah Reyes-De JesúsDepartment of Pediatrics, Medical Sciences Campus, School of Medicine, University of Puerto Rico, San Juan 00921, Puerto Rico.
Ricardo A MosqueraDepartment of Pediatrics, Houston Medical School, University of Texas Health Science Center, Houston, TX 77030, USA.
University of Puerto Rico, Medical Sciences Campus · PRThe University of Texas Health Science Center at Houston · US

Funding

Institutional Career Development CoreKL2TR003168 · NCATS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MILLER, CHARLES C · 2019 to 2023
$4.9M
Department of Health and Human Services, Health Resources and Services Administration, Bureau of Health Workforce. D34HP24463NCATS NIH HHS KL2 TR003168
6 · The paper itself

Abstract

Primary ciliary dyskinesia (PCD) is a rare, heterogeneous ciliopathy resulting in chronic oto-sino-pulmonary disease, bronchiectasis, newborn respiratory distress, and laterality defects. PCD diagnosis can be achieved by following diagnostic algorithms that include electron microscopy, genetics, and ancillary testing. Genetic mutations in more than 45 genes, including

Indexed as

ciliafounder mutationprimary ciliary dyskinesiaPuerto RicoRSPH4A

Identifiers

PMID33670432
PMCPMC7918725
OpenAlexW3128893373

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.